Kuchyne na miru


Apr 29, 2019
The UK has had in place what amount to two pricing schemes for branded medicines for years. But with major changes to both schemes set out in 2018, it’s now a new tale of two pricing schemes. Leela Barham reports.
Jan 22, 2019
“You wanna play rough? Just try it!” was the gist of the New-Year message from the European pharma industry to the healthcare authorities circling around drug firms preparing for pricing discussions. Reflector reports.
Jan 08, 2019
While more are now achieving 100% compliance, life sciences companies are still grappling with implementation of the policy and procedure changes under the GDPR, writes Ashley Williams.
Dec 21, 2018
As the EU prepares for a change of governance, policymakers should take note of recent comments about the "poisoned atmosphere" surrounding healthcare policy debates, writes Reflector.
Oct 24, 2018
Seven years ago, the UK Bribery Act 2010 was deemed revolutionary. Looking back, what has been its impact on pharma? Chris Cartmell and Jo Pisano report.
Oct 09, 2018
Pharmaceutical Executive
What will come out of Austria’s shakeup of European pharma rules? Reflector reports.
Aug 24, 2018
A recently announced collaboration between EUnetHTA, WHO, and ISPOR brings home the fact that there is still no real agreement on a definition of HTA, writes Reflector.
Aug 01, 2018
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.
Jul 27, 2018
Artificial intelligence adoption by pharma companies in the UK demands a new, agile governance layer, write Tim Wright and Antony Bott.
Jul 09, 2018
Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.
красивые детские платья

удаление тату одесса

lorem ipsum